{"transactions":[{"id":941798,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-09T16:30:24.000Z","date":"2026-01-07","kind":"grant","planned":false,"acquired":true,"shares":690900,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":690900,"derivative":{"exercise_price":0.055,"exercise_date":"2026-01-07","expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":690900},"source":{"system":"sec-edgar","filing":"0001213900-26-002949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650504/000121390026002949/ownership.xml","form_type":"4"}},{"id":1127179,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-02T17:06:49.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":9326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the 1/3 time-based portion of an award of options to purchase 27,979 shares, vesting in equal monthly installments on the 4th of each month from July 4, 2025 through March 4, 2026, with the remaining portion subject to performance conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the 1/3 time-based portion of an award of options to purchase 27,979 shares, vesting in equal monthly installments on the 4th of each month from July 4, 2025 through March 4, 2026, with the remaining portion subject to performance conditions."}],"balance_after":9326,"derivative":{"exercise_price":0.4454,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":9326},"source":{"system":"sec-edgar","filing":"0001213900-25-050123","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650504/000121390025050123/ownership.xml","form_type":"4"}},{"id":1219018,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-06T16:16:51.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":17923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the 50% time-based portion of an award of options to purchase 35,846 shares, vesting on the twelve month anniversary of the grant date, with the remaining portion subject to performance conditions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the 50% time-based portion of an award of options to purchase 35,846 shares, vesting on the twelve month anniversary of the grant date, with the remaining portion subject to performance conditions."}],"balance_after":17923,"derivative":{"exercise_price":1.43,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":17923},"source":{"system":"sec-edgar","filing":"0001213900-25-021190","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650504/000121390025021190/ownership.xml","form_type":"4"}},{"id":1242434,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-26T18:06:06.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":127500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 1, 2024, the Reporting Person was granted an option to purchase 255,000 shares of Common Stock, which vest in two equal installments subject to the satisfaction of certain performance criteria. On February 24, 2025, the Issuer's Board of Directors confirmed that the performance criteria had been met with regards to the second installment, resulting in the vesting of 127,500 shares."}],"balance_after":255000,"derivative":{"exercise_price":0.1,"expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":127500},"source":{"system":"sec-edgar","filing":"0001213900-25-017524","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650504/000121390025017524/ownership.xml","form_type":"4"}},{"id":1342460,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-04T21:12:24.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":127500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 1, 2024, the Reporting Person was granted an option to purchase 255,000 shares of Common Stock, which vest in two equal installments subject to the satisfaction of certain performance criteria. On December 2, 2024, the Issuer's Board of Directors confirmed that the performance criteria had been met with regards to one installment, resulting in the vesting of 127,500 shares."}],"balance_after":127500,"derivative":{"exercise_price":0.1,"expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":127500},"source":{"system":"sec-edgar","filing":"0001213900-24-105729","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650504/000121390024105729/ownership.xml","form_type":"4"}},{"id":1559204,"issuer":{"id":8622,"kind":"organization","name":"CERO THERAPEUTICS HOLDINGS, INC."},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-27T21:29:22.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in thirty-six (36) monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":112500,"derivative":{"exercise_price":1.77,"expiration_date":"2034-03-24","underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001213900-24-026824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650504/000121390024026824/ownership.xml","form_type":"4"}},{"id":1853948,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T18:10:20.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":1.18,"expiration_date":"2023-06-12","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-23-037521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532346/000120919123037521/doc4.xml","form_type":"4"}},{"id":2125469,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-11-03T16:15:14.000Z","date":"2022-11-01","kind":"exercise","acquired":false,"shares":4625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":23125,"derivative":{"underlying":"Common Stock","underlying_shares":4625},"source":{"system":"sec-edgar","filing":"0000899243-22-034890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322034890/doc4.xml","form_type":"4"}},{"id":2125468,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-11-03T16:15:14.000Z","date":"2022-11-01","kind":"exercise","acquired":false,"shares":3749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":3749},"source":{"system":"sec-edgar","filing":"0000899243-22-034890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322034890/doc4.xml","form_type":"4"}},{"id":2125467,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-11-03T16:15:14.000Z","date":"2022-11-02","kind":"sale","acquired":false,"shares":2353,"price":0.9829,"value":2312.7637,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $ 0.9621 to $9.9830. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":113691,"source":{"system":"sec-edgar","filing":"0000899243-22-034890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322034890/doc4.xml","form_type":"4"}},{"id":2125466,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-11-03T16:15:14.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":4625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":116044,"source":{"system":"sec-edgar","filing":"0000899243-22-034890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322034890/doc4.xml","form_type":"4"}},{"id":2125465,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-11-03T16:15:14.000Z","date":"2022-11-02","kind":"sale","acquired":false,"shares":1908,"price":0.9829,"value":1875.3732,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $ 0.9621 to $9.9830. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":111419,"source":{"system":"sec-edgar","filing":"0000899243-22-034890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322034890/doc4.xml","form_type":"4"}},{"id":2125464,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-11-03T16:15:14.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":3749,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":113327,"source":{"system":"sec-edgar","filing":"0000899243-22-034890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322034890/doc4.xml","form_type":"4"}},{"id":2165544,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-09-06T16:15:35.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":5063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 1, 2021, the reporting person was granted 81,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2022, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 1, 2021, the reporting person was granted 81,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2022, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date"}],"balance_after":50625,"derivative":{"underlying":"Common Stock","underlying_shares":5063},"source":{"system":"sec-edgar","filing":"0000899243-22-030421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322030421/doc4.xml","form_type":"4"}},{"id":2165543,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-06T16:15:35.000Z","date":"2022-09-02","kind":"sale","acquired":false,"shares":2545,"price":1.2,"value":3054.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":109578,"source":{"system":"sec-edgar","filing":"0000899243-22-030421","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322030421/doc4.xml","form_type":"4"}},{"id":2165542,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-06T16:15:35.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":5063,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":112123,"source":{"system":"sec-edgar","filing":"0000899243-22-030421","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322030421/doc4.xml","form_type":"4"}},{"id":2195657,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-08-03T16:15:52.000Z","date":"2022-08-01","kind":"exercise","acquired":false,"shares":4625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":27750,"derivative":{"underlying":"Common Stock","underlying_shares":4625},"source":{"system":"sec-edgar","filing":"0000899243-22-027577","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322027577/doc4.xml","form_type":"4"}},{"id":2195656,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-08-03T16:15:52.000Z","date":"2022-08-01","kind":"exercise","acquired":false,"shares":3749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":7499,"derivative":{"underlying":"Common Stock","underlying_shares":3749},"source":{"system":"sec-edgar","filing":"0000899243-22-027577","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322027577/doc4.xml","form_type":"4"}},{"id":2195655,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-03T16:15:52.000Z","date":"2022-08-02","kind":"sale","acquired":false,"shares":2391,"price":1.4609,"value":3493.0119,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $ 1.4600 to $1.4947. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":107060,"source":{"system":"sec-edgar","filing":"0000899243-22-027577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322027577/doc4.xml","form_type":"4"}},{"id":2195654,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-03T16:15:52.000Z","date":"2022-08-01","kind":"exercise","acquired":true,"shares":4625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":109451,"source":{"system":"sec-edgar","filing":"0000899243-22-027577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322027577/doc4.xml","form_type":"4"}},{"id":2195653,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-03T16:15:52.000Z","date":"2022-08-02","kind":"sale","acquired":false,"shares":1939,"price":1.4609,"value":2832.6851,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $ 1.4600 to $1.4947. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":104826,"source":{"system":"sec-edgar","filing":"0000899243-22-027577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322027577/doc4.xml","form_type":"4"}},{"id":2195652,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-08-03T16:15:52.000Z","date":"2022-08-01","kind":"exercise","acquired":true,"shares":3749,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":106765,"source":{"system":"sec-edgar","filing":"0000899243-22-027577","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322027577/doc4.xml","form_type":"4"}},{"id":2235479,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T18:42:35.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":2.09,"expiration_date":"2032-06-07","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-22-036101","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532346/000120919122036101/doc4.xml","form_type":"4"}},{"id":2244526,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-06-03T16:15:40.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":5062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 1, 2021, the reporting person was granted 81,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2022, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 1, 2021, the reporting person was granted 81,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2022, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date"}],"balance_after":55688,"derivative":{"underlying":"Common Stock","underlying_shares":5062},"source":{"system":"sec-edgar","filing":"0000899243-22-020946","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322020946/doc4.xml","form_type":"4"}},{"id":2244525,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-06-03T16:15:40.000Z","date":"2022-06-02","kind":"sale","acquired":false,"shares":2650,"price":0.6425,"value":1702.625,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $0.642368 to $0.645500. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":103016,"source":{"system":"sec-edgar","filing":"0000899243-22-020946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322020946/doc4.xml","form_type":"4"}},{"id":2244524,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-06-03T16:15:40.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":5062,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":105666,"source":{"system":"sec-edgar","filing":"0000899243-22-020946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322020946/doc4.xml","form_type":"4"}},{"id":2284131,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-05-03T16:15:36.000Z","date":"2022-05-01","kind":"exercise","acquired":false,"shares":4625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":32375,"derivative":{"underlying":"Common Stock","underlying_shares":4625},"source":{"system":"sec-edgar","filing":"0000899243-22-016295","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322016295/doc4.xml","form_type":"4"}},{"id":2284130,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-05-03T16:15:36.000Z","date":"2022-05-01","kind":"exercise","acquired":false,"shares":3749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":11248,"derivative":{"underlying":"Common Stock","underlying_shares":3749},"source":{"system":"sec-edgar","filing":"0000899243-22-016295","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322016295/doc4.xml","form_type":"4"}},{"id":2284129,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-05-03T16:15:36.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":2348,"price":1.9698,"value":4625.0904,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $1.9518 to $1.9700. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":100604,"source":{"system":"sec-edgar","filing":"0000899243-22-016295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322016295/doc4.xml","form_type":"4"}},{"id":2284128,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-05-03T16:15:36.000Z","date":"2022-05-01","kind":"exercise","acquired":true,"shares":4625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":102952,"source":{"system":"sec-edgar","filing":"0000899243-22-016295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322016295/doc4.xml","form_type":"4"}},{"id":2284127,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-05-03T16:15:36.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":1904,"price":1.9698,"value":3750.4992,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $1.9518 to $1.9700. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":98327,"source":{"system":"sec-edgar","filing":"0000899243-22-016295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322016295/doc4.xml","form_type":"4"}},{"id":2284126,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-05-03T16:15:36.000Z","date":"2022-05-01","kind":"exercise","acquired":true,"shares":3749,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":100231,"source":{"system":"sec-edgar","filing":"0000899243-22-016295","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322016295/doc4.xml","form_type":"4"}},{"id":2354081,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-03-03T16:15:41.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 1, 2018 , the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 1, 2018 , the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":688},"source":{"system":"sec-edgar","filing":"0000899243-22-009062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322009062/doc4.xml","form_type":"4"}},{"id":2354080,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-03-03T16:15:41.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":20250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 1, 2021, the reporting person was granted 81,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2022, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 1, 2021, the reporting person was granted 81,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2022, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date"}],"balance_after":60750,"derivative":{"underlying":"Common Stock","underlying_shares":20250},"source":{"system":"sec-edgar","filing":"0000899243-22-009062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322009062/doc4.xml","form_type":"4"}},{"id":2354079,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-03-03T16:15:41.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Restricted Stock Units shall vest as to 25% of the units on March 1, 2023, and the remainder shall vest in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Restricted Stock Units shall vest as to 25% of the units on March 1, 2023, and the remainder shall vest in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":81000,"derivative":{"underlying":"Common Stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0000899243-22-009062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322009062/doc4.xml","form_type":"4"}},{"id":2354078,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-03T16:15:41.000Z","date":"2022-03-02","kind":"sale","acquired":false,"shares":10585,"price":1.866,"value":19751.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $1.862 to $1.866. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":96482,"source":{"system":"sec-edgar","filing":"0000899243-22-009062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322009062/doc4.xml","form_type":"4"}},{"id":2354077,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-03T16:15:41.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":20250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":107067,"source":{"system":"sec-edgar","filing":"0000899243-22-009062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322009062/doc4.xml","form_type":"4"}},{"id":2354076,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-03T16:15:41.000Z","date":"2022-03-02","kind":"sale","acquired":false,"shares":360,"price":1.866,"value":671.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $1.862 to $1.866. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":86817,"source":{"system":"sec-edgar","filing":"0000899243-22-009062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322009062/doc4.xml","form_type":"4"}},{"id":2354075,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-03T16:15:41.000Z","date":"2022-03-01","kind":"exercise","acquired":true,"shares":688,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":87177,"source":{"system":"sec-edgar","filing":"0000899243-22-009062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322009062/doc4.xml","form_type":"4"}},{"id":2413666,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-02-03T16:17:12.000Z","date":"2022-02-01","kind":"exercise","acquired":false,"shares":4625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":37000,"derivative":{"underlying":"Common Stock","underlying_shares":4625},"source":{"system":"sec-edgar","filing":"0000899243-22-004583","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322004583/doc4.xml","form_type":"4"}},{"id":2413665,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-02-03T16:17:12.000Z","date":"2022-02-01","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":14997,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0000899243-22-004583","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322004583/doc4.xml","form_type":"4"}},{"id":2413664,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-03T16:17:12.000Z","date":"2022-02-02","kind":"sale","acquired":false,"shares":2493,"price":1.9397,"value":4835.6721,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $1.89 to $1.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":86489,"source":{"system":"sec-edgar","filing":"0000899243-22-004583","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322004583/doc4.xml","form_type":"4"}},{"id":2413663,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-03T16:17:12.000Z","date":"2022-02-01","kind":"exercise","acquired":true,"shares":4625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":88982,"source":{"system":"sec-edgar","filing":"0000899243-22-004583","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322004583/doc4.xml","form_type":"4"}},{"id":2413662,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-03T16:17:12.000Z","date":"2022-02-02","kind":"sale","acquired":false,"shares":2021,"price":1.9396,"value":3919.9316,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $1.89 to $1.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":84357,"source":{"system":"sec-edgar","filing":"0000899243-22-004583","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322004583/doc4.xml","form_type":"4"}},{"id":2413661,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-02-03T16:17:12.000Z","date":"2022-02-01","kind":"exercise","acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":86378,"source":{"system":"sec-edgar","filing":"0000899243-22-004583","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924322004583/doc4.xml","form_type":"4"}},{"id":2485715,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-12-03T16:16:05.000Z","date":"2021-12-01","kind":"exercise","acquired":false,"shares":687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F3","text":"On March 1, 2018, the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 1, 2018, the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 1, 2018, the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":688,"derivative":{"underlying":"Common Stock","underlying_shares":687},"source":{"system":"sec-edgar","filing":"0000899243-21-046772","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321046772/doc4.xml","form_type":"4"}},{"id":2485714,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-03T16:16:05.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":346,"price":3,"value":1038.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 1, 2018, the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":82628,"source":{"system":"sec-edgar","filing":"0000899243-21-046772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321046772/doc4.xml","form_type":"4"}},{"id":2485713,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-03T16:16:05.000Z","date":"2021-12-01","kind":"exercise","acquired":true,"shares":687,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":82974,"source":{"system":"sec-edgar","filing":"0000899243-21-046772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321046772/doc4.xml","form_type":"4"}},{"id":2526137,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-11-03T16:18:55.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":4625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F4","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":41625,"derivative":{"underlying":"Common Stock","underlying_shares":4625},"source":{"system":"sec-edgar","filing":"0000899243-21-042707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321042707/doc4.xml","form_type":"4"}},{"id":2526136,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-11-03T16:18:55.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":3749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F3","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":18747,"derivative":{"underlying":"Common Stock","underlying_shares":3749},"source":{"system":"sec-edgar","filing":"0000899243-21-042707","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321042707/doc4.xml","form_type":"4"}},{"id":2526135,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-11-03T16:18:55.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":2325,"price":4.55,"value":10578.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":82287,"source":{"system":"sec-edgar","filing":"0000899243-21-042707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321042707/doc4.xml","form_type":"4"}},{"id":2526134,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-11-03T16:18:55.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":4625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":84612,"source":{"system":"sec-edgar","filing":"0000899243-21-042707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321042707/doc4.xml","form_type":"4"}},{"id":2526133,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-11-03T16:18:55.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":1884,"price":4.55,"value":8572.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":79987,"source":{"system":"sec-edgar","filing":"0000899243-21-042707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321042707/doc4.xml","form_type":"4"}},{"id":2526132,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-11-03T16:18:55.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":3749,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":81871,"source":{"system":"sec-edgar","filing":"0000899243-21-042707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321042707/doc4.xml","form_type":"4"}},{"id":2579159,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-09-03T16:15:17.000Z","date":"2021-09-01","kind":"exercise","acquired":false,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F4","text":"On March 1, 2018, the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 1, 2018, the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 1, 2018, the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":1375,"derivative":{"underlying":"Common Stock","underlying_shares":688},"source":{"system":"sec-edgar","filing":"0000899243-21-035113","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321035113/doc4.xml","form_type":"4"}},{"id":2579158,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-03T16:15:17.000Z","date":"2021-09-02","kind":"sale","acquired":false,"shares":347,"price":4.89,"value":1696.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.88 to $4.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":78122,"source":{"system":"sec-edgar","filing":"0000899243-21-035113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321035113/doc4.xml","form_type":"4"}},{"id":2579157,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-03T16:15:17.000Z","date":"2021-09-01","kind":"exercise","acquired":true,"shares":688,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":78469,"source":{"system":"sec-edgar","filing":"0000899243-21-035113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321035113/doc4.xml","form_type":"4"}},{"id":2617545,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-08-03T21:32:37.000Z","date":"2021-08-01","kind":"exercise","acquired":false,"shares":4625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":46250,"derivative":{"underlying":"Common Stock","underlying_shares":4625},"source":{"system":"sec-edgar","filing":"0000899243-21-031440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321031440/doc4.xml","form_type":"4"}},{"id":2617544,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-08-03T21:32:37.000Z","date":"2021-08-01","kind":"exercise","acquired":false,"shares":3749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.82 to $4.85. The price reported above reflects the weighted average sale price. The reporting\nperson hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and\nprices at which the transaction was effected."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":22496,"derivative":{"underlying":"Common Stock","underlying_shares":3749},"source":{"system":"sec-edgar","filing":"0000899243-21-031440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321031440/doc4.xml","form_type":"4"}},{"id":2617543,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-03T21:32:37.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":2317,"price":4.82,"value":11167.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.82 to $4.85. The price reported above reflects the weighted average sale price. The reporting\nperson hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and\nprices at which the transaction was effected."}],"balance_after":77781,"source":{"system":"sec-edgar","filing":"0000899243-21-031440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321031440/doc4.xml","form_type":"4"}},{"id":2617542,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-03T21:32:37.000Z","date":"2021-08-01","kind":"exercise","acquired":true,"shares":4625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":80098,"source":{"system":"sec-edgar","filing":"0000899243-21-031440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321031440/doc4.xml","form_type":"4"}},{"id":2617541,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-03T21:32:37.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":1878,"price":4.82,"value":9051.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $4.82 to $4.85. The price reported above reflects the weighted average sale price. The reporting\nperson hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and\nprices at which the transaction was effected."}],"balance_after":75473,"source":{"system":"sec-edgar","filing":"0000899243-21-031440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321031440/doc4.xml","form_type":"4"}},{"id":2617540,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-08-03T21:32:37.000Z","date":"2021-08-01","kind":"exercise","acquired":true,"shares":3749,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":77351,"source":{"system":"sec-edgar","filing":"0000899243-21-031440","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321031440/doc4.xml","form_type":"4"}},{"id":2671372,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T16:31:14.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date.  All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control."}],"balance_after":12000,"derivative":{"exercise_price":10.27,"expiration_date":"2031-06-08","underlying":"Class A Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-039839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532346/000120919121039839/doc4.xml","form_type":"4"}},{"id":2683145,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-06-03T19:00:58.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 1, 2018, the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 1, 2018, the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":2063,"derivative":{"underlying":"Common Stock","underlying_shares":687},"source":{"system":"sec-edgar","filing":"0000899243-21-021857","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321021857/doc4.xml","form_type":"4"}},{"id":2683144,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-06-03T19:00:58.000Z","date":"2021-06-03","kind":"sale","acquired":false,"shares":322,"price":5.63,"value":1812.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":73602,"source":{"system":"sec-edgar","filing":"0000899243-21-021857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321021857/doc4.xml","form_type":"4"}},{"id":2683143,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-06-03T19:00:58.000Z","date":"2021-06-01","kind":"exercise","acquired":true,"shares":687,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":73924,"source":{"system":"sec-edgar","filing":"0000899243-21-021857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321021857/doc4.xml","form_type":"4"}},{"id":2729981,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-05-04T21:39:22.000Z","date":"2021-05-01","kind":"exercise","acquired":false,"shares":4625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F4","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":50875,"derivative":{"underlying":"Common Stock","underlying_shares":4625},"source":{"system":"sec-edgar","filing":"0000899243-21-018276","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321018276/doc4.xml","form_type":"4"}},{"id":2729980,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-05-04T21:39:22.000Z","date":"2021-05-01","kind":"exercise","acquired":false,"shares":3749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F3","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":26245,"derivative":{"underlying":"Common Stock","underlying_shares":3749},"source":{"system":"sec-edgar","filing":"0000899243-21-018276","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321018276/doc4.xml","form_type":"4"}},{"id":2729979,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-05-04T21:39:22.000Z","date":"2021-05-04","kind":"sale","acquired":false,"shares":2486,"price":5.54,"value":13772.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $5.53 to $5.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":73237,"source":{"system":"sec-edgar","filing":"0000899243-21-018276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321018276/doc4.xml","form_type":"4"}},{"id":2729978,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-05-04T21:39:22.000Z","date":"2021-05-01","kind":"exercise","acquired":true,"shares":4625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":75723,"source":{"system":"sec-edgar","filing":"0000899243-21-018276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321018276/doc4.xml","form_type":"4"}},{"id":2729977,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-05-04T21:39:22.000Z","date":"2021-05-04","kind":"sale","acquired":false,"shares":2015,"price":5.54,"value":11163.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $5.53 to $5.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":71098,"source":{"system":"sec-edgar","filing":"0000899243-21-018276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321018276/doc4.xml","form_type":"4"}},{"id":2729976,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-05-04T21:39:22.000Z","date":"2021-05-01","kind":"exercise","acquired":true,"shares":3749,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":73113,"source":{"system":"sec-edgar","filing":"0000899243-21-018276","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321018276/doc4.xml","form_type":"4"}},{"id":2812956,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-03-03T18:35:03.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 1, 2018 , the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 1, 2018 , the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":2750,"derivative":{"underlying":"Common Stock","underlying_shares":688},"source":{"system":"sec-edgar","filing":"0000899243-21-009493","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321009493/doc4.xml","form_type":"4"}},{"id":2812955,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-03-03T18:35:03.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 27, 2017, the reporting person was granted 10,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 27, 2017, the reporting person was granted 10,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0000899243-21-009493","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321009493/doc4.xml","form_type":"4"}},{"id":2812954,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-03-03T18:35:03.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":81000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Restricted Stock Units shall vest as to 25% of the units on March 1, 2022, and the remainder shall vest in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Restricted Stock Units shall vest as to 25% of the units on March 1, 2022, and the remainder shall vest in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":81000,"derivative":{"underlying":"Common Stock","underlying_shares":81000},"source":{"system":"sec-edgar","filing":"0000899243-21-009493","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321009493/doc4.xml","form_type":"4"}},{"id":2812953,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-03T18:35:03.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":346,"price":6.29,"value":2176.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":69364,"source":{"system":"sec-edgar","filing":"0000899243-21-009493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321009493/doc4.xml","form_type":"4"}},{"id":2812952,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-03T18:35:03.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":688,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":69710,"source":{"system":"sec-edgar","filing":"0000899243-21-009493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321009493/doc4.xml","form_type":"4"}},{"id":2812951,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-03T18:35:03.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":315,"price":6.29,"value":1981.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":69022,"source":{"system":"sec-edgar","filing":"0000899243-21-009493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321009493/doc4.xml","form_type":"4"}},{"id":2812950,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-03T18:35:03.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":69337,"source":{"system":"sec-edgar","filing":"0000899243-21-009493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321009493/doc4.xml","form_type":"4"}},{"id":2881625,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-02-03T16:15:33.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":18500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F5","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":55500,"derivative":{"underlying":"Common Stock","underlying_shares":18500},"source":{"system":"sec-edgar","filing":"0000899243-21-004675","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321004675/doc4.xml","form_type":"4"}},{"id":2881624,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-02-03T16:15:33.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":29994,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0000899243-21-004675","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321004675/doc4.xml","form_type":"4"}},{"id":2881623,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-03T16:15:33.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":9822,"price":7.97,"value":78281.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $7.97 to $8.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":68712,"source":{"system":"sec-edgar","filing":"0000899243-21-004675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321004675/doc4.xml","form_type":"4"}},{"id":2881622,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-03T16:15:33.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":18500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":78534,"source":{"system":"sec-edgar","filing":"0000899243-21-004675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321004675/doc4.xml","form_type":"4"}},{"id":2881621,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-03T16:15:33.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":1991,"price":7.97,"value":15868.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $7.97 to $8.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":60034,"source":{"system":"sec-edgar","filing":"0000899243-21-004675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321004675/doc4.xml","form_type":"4"}},{"id":2881620,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-03T16:15:33.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":62025,"source":{"system":"sec-edgar","filing":"0000899243-21-004675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924321004675/doc4.xml","form_type":"4"}},{"id":2932807,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2020-12-23T16:52:40.000Z","date":"2020-12-21","kind":"exercise","acquired":false,"shares":3438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F3","text":"On December 19, 2016, the reporting person was granted 55,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on December 19, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On December 19, 2016, the reporting person was granted 55,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on December 19, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On December 19, 2016, the reporting person was granted 55,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on December 19, 2017, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3438},"source":{"system":"sec-edgar","filing":"0000899243-20-034998","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320034998/doc4.xml","form_type":"4"}},{"id":2932806,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-23T16:52:40.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":1728,"price":5.68,"value":9815.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":58275,"source":{"system":"sec-edgar","filing":"0000899243-20-034998","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320034998/doc4.xml","form_type":"4"}},{"id":2932805,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-23T16:52:40.000Z","date":"2020-12-21","kind":"exercise","acquired":true,"shares":3438,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":60003,"source":{"system":"sec-edgar","filing":"0000899243-20-034998","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320034998/doc4.xml","form_type":"4"}},{"id":2942444,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-16T16:15:27.000Z","date":"2020-12-15","kind":"exercise","acquired":false,"shares":17241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested as to 25% of the shares on March 1, 2012, and the remainder vested in substantially equal installments over the 36 months immediately following such date."}],"balance_after":0,"derivative":{"exercise_price":3.28,"expiration_date":"2021-03-01","underlying":"Common Stock","underlying_shares":17241},"source":{"system":"sec-edgar","filing":"0000899243-20-034109","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320034109/doc4.xml","form_type":"4"}},{"id":2942443,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-16T16:15:27.000Z","date":"2020-12-15","kind":"tax_withholding","acquired":false,"shares":14153,"price":5.11,"value":72321.83,"ownership":{"direct":true},"balance_after":56565,"source":{"system":"sec-edgar","filing":"0000899243-20-034109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320034109/doc4.xml","form_type":"4"}},{"id":2942442,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-16T16:15:27.000Z","date":"2020-12-15","kind":"exercise","acquired":true,"shares":17241,"price":3.28,"value":56550.48,"ownership":{"direct":true},"balance_after":70718,"source":{"system":"sec-edgar","filing":"0000899243-20-034109","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320034109/doc4.xml","form_type":"4"}},{"id":2955115,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2020-12-07T21:45:41.000Z","date":"2020-12-03","kind":"exercise","acquired":false,"shares":687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F4","text":"On March 1, 2018 , the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 1, 2018 , the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 1, 2018 , the reporting person was granted 11,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":3438,"derivative":{"underlying":"Common Stock","underlying_shares":687},"source":{"system":"sec-edgar","filing":"0000899243-20-032938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320032938/doc4.xml","form_type":"4"}},{"id":2955114,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2020-12-07T21:45:41.000Z","date":"2020-12-03","kind":"exercise","acquired":false,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F3","text":"On March 27, 2017, the reporting person was granted 10,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 27, 2017, the reporting person was granted 10,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On March 27, 2017, the reporting person was granted 10,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2018, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":625,"derivative":{"underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0000899243-20-032938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320032938/doc4.xml","form_type":"4"}},{"id":2955113,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-07T21:45:41.000Z","date":"2020-12-03","kind":"sale","acquired":false,"shares":346,"price":4.89,"value":1691.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":53477,"source":{"system":"sec-edgar","filing":"0000899243-20-032938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320032938/doc4.xml","form_type":"4"}},{"id":2955112,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-07T21:45:41.000Z","date":"2020-12-03","kind":"exercise","acquired":true,"shares":687,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":53823,"source":{"system":"sec-edgar","filing":"0000899243-20-032938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320032938/doc4.xml","form_type":"4"}},{"id":2955111,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-07T21:45:41.000Z","date":"2020-12-03","kind":"sale","acquired":false,"shares":315,"price":4.89,"value":1540.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":53136,"source":{"system":"sec-edgar","filing":"0000899243-20-032938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320032938/doc4.xml","form_type":"4"}},{"id":2955110,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-07T21:45:41.000Z","date":"2020-12-03","kind":"exercise","acquired":true,"shares":625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."}],"balance_after":53451,"source":{"system":"sec-edgar","filing":"0000899243-20-032938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320032938/doc4.xml","form_type":"4"}},{"id":2991030,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2020-11-05T16:18:18.000Z","date":"2020-11-03","kind":"exercise","acquired":false,"shares":3749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents the right to receive one share of Common Stock."},{"field":"date","element":"transactionDate","label":"F3","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 1, 2019, the reporting person was granted 59,988 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date."}],"balance_after":33744,"derivative":{"underlying":"Common Stock","underlying_shares":3749},"source":{"system":"sec-edgar","filing":"0000899243-20-030475","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320030475/doc4.xml","form_type":"4"}},{"id":2991029,"issuer":{"id":122635,"kind":"organization","name":"Clovis Oncology, Inc.","symbol":"CLVS"},"owners":[{"id":69617,"kind":"person","name":"Rolfe Lindsey","position":1,"cik":"0001650504","reported_name":"Rolfe Lindsey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-11-05T16:18:18.000Z","date":"2020-11-03","kind":"sale","acquired":false,"shares":1920,"price":4.93,"value":9465.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":52826,"source":{"system":"sec-edgar","filing":"0000899243-20-030475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1466301/000089924320030475/doc4.xml","form_type":"4"}}],"next_cursor":"2020-11-05T16:18:18.000000Z,2991029"}